Evidence map›Paper›PMID 38725300›Full record

ArticleInternational journal of epidemiology2024

Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis.

Emmanouil Bouras, Dipender Gill, Verena Zuber, Neil Murphy, Niki Dimou, Krasimira Aleksandrova, Sarah J Lewis, Richard M Martin, James Yarmolinsky, Demetrius Albanes and 17 more

Abstract read
In one paragraph

Article in International journal of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Emmanouil BourasDepartment of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.ORCID 0000-0003-1489-5506
Dipender GillChief Scientific Advisor Office, Research and Early Development, Novo Nordisk, Copenhagen, Denmark.ORCID 0000-0001-7312-7078
Verena ZuberDepartment of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, UK.ORCID 0000-0001-9827-1877
Neil MurphyNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-3347-8249
Niki DimouNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Krasimira AleksandrovaFaculty of Human and Health Sciences, University of Bremen, Bremen, Germany.ORCID 0000-0002-1275-1827
Sarah J LewisDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Richard M MartinDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
James YarmolinskyDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sergi Castellví-BelDepartment of Gastroenterology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Clínic, Barcelona, Spain.
Andrew T ChanDivision of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Iona ChengDepartment of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA, USA.ORCID 0000-0003-4132-2893
Stephen GruberDepartment of Medical Oncology & Therapeutics Research and Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA.
Bethany Van GuelpenDepartment of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden.ORCID 0000-0002-9692-101X
Christopher I LiPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Loic Le MarchandUniversity of Hawaii Cancer Center, Honolulu, HI, USA.
Polly A NewcombPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Shuji OginoBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Andrew PellattDepartment of Medicine, University of Utah, Salt Lake City, UT, USA.
Stephanie L SchmitGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Alicja WolkInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-7387-6845
Anna H WuUniversity of Southern California, Preventative Medicine, Los Angeles, CA, USA.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Marc J GunterDepartment of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, UK.
Konstantinos K TsilidisDepartment of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

Funding

Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
Using Functional Genomics to Inform Gene Environment Interactions for Colorectal CancerR01CA201407 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CASEY, GRAHAM, GAUDERMAN, WILLIAM JAMES · 2016 to 2020
$9.6M
An integrative omics approach to investigate gene-environment interaction in colorectal cancer riskR01CA273198 · NCI · FRED HUTCHINSON CANCER CENTER · PI William JAMES GAUDERMAN, ULRIKE PETERS · 2023 to 2026
$3.5M
Cancer Research UK 29019Medical Research Council MC_UU_00011/1Medical Research Council MC_UU_00011/6NCI NIH HHS R01 CA201407NCI NIH HHS R01 CA273198NCI NIH HHS U01 CA167551World Health Organization 001
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is the third-most-common cancer worldwide and its rates are increasing. Elevated body mass index (BMI) is an established risk factor for CRC, although the molecular mechanisms behind this association remain unclear. Using the Mendelian randomization (MR) framework, we aimed to investigate the mediating effects of putative biomarkers and other CRC risk factors in the association between BMI and CRC.

methodsWe selected as mediators biomarkers of established cancer-related mechanisms and other CRC risk factors for which a plausible association with obesity exists, such as inflammatory biomarkers, glucose homeostasis traits, lipids, adipokines, insulin-like growth factor 1 (IGF1), sex hormones, 25-hydroxy-vitamin D, smoking, physical activity (PA) and alcohol consumption. We used inverse-variance weighted MR in the main univariable analyses and performed sensitivity analyses (weighted-median, MR-Egger, Contamination Mixture). We used multivariable MR for the mediation analyses.

resultsGenetically predicted BMI was positively associated with CRC risk [odds ratio per SD (5 kg/m2) = 1.17, 95% CI: 1.08-1.24, P-value = 1.4 × 10-5] and robustly associated with nearly all potential mediators. Genetically predicted IGF1, fasting insulin, low-density lipoprotein cholesterol, smoking, PA and alcohol were associated with CRC risk. Evidence for attenuation was found for IGF1 [explained 7% (95% CI: 2-13%) of the association], smoking (31%, 4-57%) and PA (7%, 2-11%). There was little evidence for pleiotropy, although smoking was bidirectionally associated with BMI and instruments were weak for PA.

conclusionsThe effect of BMI on CRC risk is possibly partly mediated through plasma IGF1, whereas the attenuation of the BMI-CRC association by smoking and PA may reflect confounding and shared underlying mechanisms rather than mediation.

Indexed as

Body Mass IndexColorectal NeoplasmsMendelian Randomization AnalysisObesityAlcohol DrinkingHumansInsulin-Like Growth Factor IRisk FactorsInsulin-Like Growth Factor IBMIBody mass indexcolorectal cancerCRCmediation analysisMendelian randomizationobesity

Identifiers

PMID38725300
PMCPMC11082423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.